and potentially against severe COVID-19 among older adults. A CDC scientist also presented modeling suggesting that booster shots could help curb cases in nursing homes, but cautioned that vaccinating seniors a
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use. The decision means many America...
Centers for Disease Control and Prevention authorized the updated bivalent COVID-19 booster for younger children on Wednesday.The new bivalent COVID booster this fall was relatively 80% effective at keeping older adults out of the hospital due to complications from the virus compared to seniors ...
Kennedy and other Trump administration appointees have been moving to narrow COVID-19 vaccine recommendations and added restrictions to a recent vaccine approval . Last week, the FDA announced routine COVID-19 vaccine approvals will be limited to seniors and younger people with underlying medical ...
But a panel of the CDC's outside experts ultimately voted Tuesday in favor of broad recommendations for the shots, thanks in part to CDC data finding that healthy, young and mostly unboosted Americans are still being hospitalized by the virus. ...
How can we address booster hesitancy or lack of knowledge around updated recommendations? While roughly42 percentof U.S. adults aged 65 or over have received a bivalent booster, this proportion drops significantly for adults aged 18 to 65, to about14 percent. But when it comes to vaccination ...
For seniors age 65 and older who feel they need some extra protection this spring, the CDC is recommending they receive yet another booster shot – provided it’s been at least four months since their last shot.
Preliminary CDC data indicated a possible stroke risk following simultaneous administration of the Pfizer Covid booster and the flu vaccine. Source:https://www.cnbc.com/2023/01/26/covid-fda-has-not-found-stroke-risk-for-seniors-who-received-pfizer-bo...
While the public has grown accustomed to calling additional shots "boosters," health officials are nowmoving away from the word "booster,"instead calling this year's shots the "2023-2024 COVID-19 vaccine" or simply the"updated COVID-19 vaccine."This clarification helps distinguish previous addit...
The Centers for Disease Control and Prevention is expanding eligibility forCOVID-19vaccine booster shots to all adults ages 18 and up. The agency published its new recommendations Friday, as health officials sound the alarm overrising casesaround the country. ...